StockData
Freenome, Inc. logo

Freenome, Inc. (FRNM) stock

FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.82−0.27 (-2.68%)

Close on Nov 17, 2026Market cap $1.09BP/E –Yield –

Freenome r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$68.42M–
Q3 FY2025Sep 30, 2025$50.63M–

More Freenome figures

See a number that looks wrong?